skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines guselkumabQuestion & answer

guselkumab · Medicine question

Besides IL-23, which receptor has guselkumab been shown to bind in vitro?

iatroX medicinesPublished 8 November 2026

The answer

Answer

Guselkumab has been shown to bind Fc-gamma receptor 1 (CD64) in vitro.

Sources for this answer

Tremfya 100 mg OnePress solution for injection in pre-filled penJanssen-Cilag Ltd (a Johnson & Johnson Company) · emc · SmPC §5.1 Pharmacodynamic properties · Version 16Document updated 13 February 2026

Sources checked 8 November 2026

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

The full medicine guide

More questions about guselkumab

Did concomitant methotrexate affect the safety or efficacy of guselkumab in psoriatic arthritis studies?Does guselkumab affect the ability to drive or use machines?Has the effect of guselkumab on human fertility been evaluated?Have serious allergic reactions, including anaphylaxis, been reported with guselkumab?How long is effective contraception recommended during and after guselkumab treatment?How much polysorbate 80 does each guselkumab Tremfya 100 mg OnePress pre-filled pen contain?

guselkumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the guselkumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX